衛生署 衛生防護中心 胸肺科 - 有關結核病的文獻
 
主頁 > 供醫生之資訊 > 有關結核病的文獻 > 2006年至2010年

有關結核病的文獻

(有關資料只供參考，並非表示已包含所有有關結核病的文獻)

2010

  • Leung CC, Yam WC, Yew WW, Ho PL, Tam CM, Law WS, Au KF, Tsui PW. T-spot TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010 Sep 15; 182(6): 834-40.
  • Chang KC, Leung CC, Yew WW. Acquired rifamycin mono-resistance and dosing schedules in HIV-related tuberculosis. Am J Respir Crit Care Med 2010 Oct 1; 182(7):983.
  • Leung CC, Leung EC, Yew WW. Can some patients with multidrug-resistant tuberculosis be cured with shorter duration of chemotherapy? Am J Respir Crit Care Med 2010 Dec 15; 182(12): 1570.
  • Leung CC, Lam TH, Ho KS, Yew WW, Tam CM, Chan WM, Law WS, Chan CK, Chang KC, Au KF. Passive smoking and tuberculosis. Arch Intern Med 2010;170(3):287-292.
  • Tam LS, Leung CC, Ying SK, Lee GK, Yim CW, Leung YY, Kun EW, Wong KK, Li EK. Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong - the role of TNF blockers in an area of high tuberculosis burden. Clin Exp Rheumatol. 2010 Aug 24. Sept-Oct : 28(5): 679-85 [Epub 2010 Oct 22]
  • Chang KC, Leung CC. The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate. Clin Infect Dis 2010 Aug 1; 51(3): 366-7; author reply 367-8.
  • van Zyl Smit RN, Pai M, Yew WW, Leung CC, Zumla A, Bateman ED, Dheda K. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J 2010 Jan; 35(1): 27-33.
  • Lange C, Yew WW, Migliori GB, Raviglione M. The European Respiratory Journal targets tuberculosis. Eur Respir J 2010 Oct; 36(4): 714-5.
  • Chang KC, Leung CC, Yew WW, Lau TY, Leung WM, Tam CM, Lam HC, Tse PS, Wong MY, Lee SN, Wat KI, Ma YH. Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis? Eur Respir J. 2010 Mar;35(3):606-13.
  • Chan CK, Bognar FA, Wong KH, Tam CM, Chan KCW, Ho CF, Chan WK, Mak IKY. The epidemiology and clinical manifestations of human immunodeficiency virus-associated tuberculosis in Hong Kong. Hong Kong Med J 2010;16:192-8.
  • Chan PK, Ng BKW, Wong CY. Bacille Calmette-Guérin osteomyelitis of the proximal femur. Hong Kong Med J 2010;16:223-6.
  • Zumla A, Yew WW, Hui DS. Emerging respiratory infections in the 21st century. Preface. Infect Dis Clin North Am 2010 Sep; 24(3) xiii-xvi.
  • van Zyl-Smit RN, Brunet L, Pai M, Yew WW. The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am 2010 Sep; 24(3): 693-703.
  • Mori T, Leung CC. Tuberculosis in the Global Aging Population. Infect Dis Clin North Am. 2010 Sep;24(3):751-768.
  • Leung CC, Lam TH, Yew WW, Chan WM, Law WS, Tam CM. Lower lung cancer mortality in obesity. Int J Epidemiol 2011 Feb; 40(1):174-82.
  • Kam KM, Sloutsky A, Yip CW, Bulled N, Seung KJ, Zignol M, Espinal M, Kim SJ. Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance. Int J Tuberc Lung Dis 2010;14(3):282-8.
  • Pang PT, Leung CC, Lee SS. Neighbourhood risk factors for tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2010;14(5):585-92.
  • Leung ECC, Leung CC, Leung WWL, Kam KM, Yew WW, Lee SN, Tam CM. Role of whole-blood interferon-gamma release assay in the diagnosis of smear-negative tuberculosis. Int J Tuberc Lung Dis 2010;14(12):1564-70.
  • Chang KC, Yew WW, Chan CY. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2010;65:1551-1561.
  • Leung KL, Yip CW, Yeung YL, Wong KL, Chan WY, Chan MY, Kam KM. Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs. J Appl Microbiol. 2010 Dec;109(6):2087-94
  • Chang KC, Leung CC, Kong FY. Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010 Oct 13; 304(14): 1554; author reply 1554-6.
  • Khor CC, Vannberg FO, Chapman SJ, Guo H, Wong SH, Walley AJ, Vukcevic D, Rautanen A, Mills TC, Chang KC, Kam KM, Crampin AC, Ngwira B, Leung CC, Tam CM, Chan CY, Sung JJ, Yew WW, Toh KY, Tay SK, Kwiatkowski D, Lienhardt C, Hien TT, Day NP, Peshu N, Marsh K, Maitland K, Scott JA, Williams TN, Berkley JA, Floyd S, Tang NL, Fine PE, Goh DL, Hill AV. CISH and susceptibility to infectious diseases. N Engl J Med 2010 June 3; 362(22): 2092-101
  • Wu P, Lau EHY, Cowling BJ, Leung CC, Tam CM, Leung GM. The transmission dynamics of tuberculosis in a recently developed Chinese city. PLoS One, 2010 May 3;5(5):e10468.
  • Lam T, Tam CM, Wong C. Review of notifiable diseases in Hong Kong, 2009. Public Health & Epidemiology Bulletin 2010;19(2):35-52.
  • Spiro SG, Niederman M, Yew WW, Porcel JM. Year in review 2009: Respiratory infections, tuberculosis, pleural diseases and lung cancer. Respirology 2010 Apr;15(3): 562-72.
  • Nuermberger EL, Spigelman MK, Yew WW. Current development and future prospects in chemotherapy of tuberculosis. Respirology 2010 Jul; 15(5):764-78.
  • Chang KC, Leung CC. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax 2010;65:271-276. doi:10.1136/thx.2009.126771.
  • Chang KC, Leung CC, Grosset J, Yew WW. Treatment of tuberculosis and optimal dosing schedules. Thorax 2010 Dec 17. [Epub ahead of print]

返回頁首

2009

  • Chang KC. Standardized regimens and the emergence of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2009;179(6):517-8.
  • Bernardo J, Yew WW. How are we creating fluoroquinolone-resistant tuberculosis? Am J Respir Crit Care Med 2009;180(4):288-9.
  • Yew WW, Leung CC. Update in tuberculosis 2008. Am J Respir Crit Care Med 2009;179:337-343.
  • Leung CC, Yew WW. Does current drug resistance surveillance provide useful information in tuberculosis? Am J Respir Crit Care Med 2009;179(1):82.
  • Perlman DC, Leung CC, Yew WW. Diagnosing tuberculosis in patients with HIV. Do we know enough? Am J Respir Crit Care Med 2009;180:800-1.
  • Mitchison DA, Chang KC. Experimental models of tuberculosis: can we trust the mouse? Am J Respir Crit Care Med 2009; 180:201-202.
  • Cheung BK, Yim HC, Lee NC, Lau AS. A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1. BMC Immunol 2009; Dec 17;10:64.
  • Leung SK, Yew WW, Leung CC. Discordance in spirometric interpretations using different reference equations. Chest 2009;136(1):324-5; author reply 325.
  • Yew WW, Leung CC. How should we treat “difficult” multidrug-resistant tuberculosis? Chest 2009;135(2):587-8.
  • Tang NL, Fan HP, Chang KC, Ching JK, Kong KP, Yew WW, Kam KM, Leung CC, Tam CM, Blackwell J, Chan CY. Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta. 2009 Aug;406(1-2):98-102.
  • Chang KC, Leung CC, Tam CM. Directly observed and standardised treatment in an era of extensively drug-resistant tuberculosis. Clin Infect Dis. 2009 Jun 1;48(11):1632-3; author reply 1633-4.
  • Leung WL, Law KL, Leung VSS, Yip CW, Leung CC, Tam CM, Kam KM. Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis. Clin Vaccine Immun 2009;16(3):344-51.
  • Kremer K, van-der-Werf MJ, Au BK, Anh DD, Kam KM, van-Doorn HR, Borgdorff MW, van-Soolingen D. Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerg Infect Dis 2009;15(2):335-9.
  • Yew WW, Chang KC, Chau CH. What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis? Eur Respir J 2009;34(6):1492-4.
  • Tam CM, Yew WW, Yuen KY. Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects. Expert Rev Clin Pharmacol 2009;2(4):405-421.
  • Cheung BKW, Chan MMP, Yim HCH, Chan LL, Li JCB, Lee DCW, Lau ASY. Immunotherapy of mycobacterial infections: a cell and molecular model. Hong Kong Med J 2009;15(Suppl 4): S32-6.
  • Mak WW, Cheung F, Woo J, Lee D, Li P, Chan KS, Tam CM. A comparative study of the stigma associated with infectious diseases (SARS, AIDS, TB). Hong Kong Med J. 2009 Dec;15 Suppl 8:34-7.
  • Cheung WI, Leung VK, Luk IS, Loke TK, Chan JC, Chau TN. Splenic tuberculosis associated with monoclonal gammopathy of undetermined significance and pericarditis. Hong Kong Med J. 2009; Aug;15(4):291-3.
  • Hui M, Chan EW, Chin ML, Au TK, Yip PC, Kam KM, Yew WW, Chan RC. Genotypic rpoB and gyrA profiles for detection of rifampicin and fluoroquinolone susceptibilities of Mycobacterium tuberculosis isolates directly from clinical sputum specimens. Int J Antimicrob Agents 2009;34(2):186-7.
  • Chiang CY, Yew WW. Multidrug-resistant and extensively drug-resistant tuberculosis – year in review 2008. Int J Tuberc Lung Dis 2009;13(3):304-311.
  • Chang KC, Leung CC, Yew WW, Lam FM, Ho PL, Chau CH, Cheng VC, Yuen KY. Analysis of fluoroquinolones and Clostridium difficile-associated diarrhea in tuberculosis patients. Int J Tuberc Lung Dis 2009;13(3):341-6.
  • Chiang CY, Yew WW. Multidrug-resistant and extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009;13(3):304-11.
  • Kam KM, Yip CW, Tang HS, Van Deun A. Bulk acid-fast staining of sputum smears: time to end a taboo. Int J Tuberc Lung Dis 2009;13(9):1119-23.
  • Chan VL, So LKY, Lam JYM, Lau KY, Chan CS, Lin AWN, Chu CM. Major haemoptysis in Hong Kong: aetiologies, angiographic findings and outcomes of bronchial artery embolisation. Int J Tuberc Lung Dis 2009;13(9):1167-1173.
  • Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009;13(11):1320-1330.
  • Yew WW, Chang KC, Chau CH. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother 2009;64(5):1119; author reply 1119-20.
  • Leung KL, Yip CW, Cheung WF, Lo AC, Ko WM, Kam KM. Development of a simple and low-cost real-time PCR method for the identification of commonly encountered mycobacteria in a high throughput laboratory. J Appl Microbiol 2009;107(5):1433-9.
  • Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, Rüsch-Gerdes S, Wright A. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol 2009;47(11):3501-6.
  • Leung CC, Yew WW. Nutrient supplementation and tuberculosis treatment outcome. J Infect Dis 2009;199(2):287-8.
  • Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M; Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009;30:373(9678):1861-73. Review.
  • Chang KC, Leung CC. Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet 2009;373(9682):2197-8; author reply 2198-9.
  • Chang KC, Leung CC, Tam CM. Household contact investigation of tuberculosis in low-income and middle-income countries: public health impact. Lancet Infect Dis. 2009;9(1):3-4.
  • Lam B, Lam SY, Wong MP, Ooi CG, Fong DY, Lam DC, Lai AY, Tam CM, Pang CB, Ip MS, Lam WK. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer. 2009 Jun;64(3):289-94.
  • Thomson RM, Yew WW. When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 2009;14(1):12-26. Review.
  • Leung CC, Chang KC. Role of interferon gamma release assays in tuberculosis. Respirology.2009;14(2):156-8.
  • Leung CC, Yew WW, Law WS, Wong MY, Tam CM, Leung SK, Tsui DP. Choice of spirometric reference values for compensation assessment. Respirology. 2009 Aug;14(6):865-72.
  • Sihoe AD, Shiraishi Y, Yew WW. The current role of thoracic surgery in tuberculosis management. Respirology 2009;14(7):954-68. Review.

返回頁首

2008

  • Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008;167(12):1486-94.
  • Chang KC, Leung CC, Tam CM. Inhaled corticosteroids might not protect against lung cancer. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1290; author reply 1290-1.
  • Chang KC, Leung CC, Yew WW, Lau TY, Tam CM. Hepatotoxicity of pyrazinamide: cohort and case-control analyses. Am J Respir Crit Care Med 2008; 177(12):1391-6.
  • Leung CC, Yew WW. Decline in prevalence of latent tuberculosis infection: is the waning of tuberculin reaction a factor? Am J Respir Crit Care Med. 2008;178(6):651-2.
  • Leung CC, Chang KC, Chau CH. Is the whole –blood gamma interferon assay better than the tuberculin skin test in predicting active tuberculosis? Am J Respir Crit Care Med. 2008;178(2):210-1.
  • Leung CC, Bailey WC, Yew WW. Screening contacts of tuberculosis: overcoming obstacles with an old tool. Am J Respir Crit Care Med 2008;177:939-40.
  • Leung CC, Yew WW. Study on twins: a good tool for infectious diseases? Am J Respir Crit Care Med 2008;177:799-800.
  • Yew WW, Leung CC. Update in tuberculosis 2007. Am J Respir Crit Care Med. 2008 1;177:479-85.
  • Leung CC, Yew WW. Can the interferon-gamma release assay help diagnose active tuberculosis in the elderly? Chest 2008;134(2):471.
  • Chang KC, Leung CC, Yew WW, Kam KM, Yip CW, Ma CH, Tam CM, Leung EC, Law WS, Leung WM. Peak plasma rifampicin level in tuberculosis patients with slow culture conversion. Eur J Clin Microbiol Infect Dis 2008;27(6):467-72.
  • Chang KC, Leung CC, Yew WW, Tam CM. Supervised and induced sputum among patients with smear-negative pulmonary tuberculosis. Eur Respir J 2008;31:1085-90.
  • Leung CC, Yam WC, Yew WW, Ho PL, Tam CM, Law WS, Wong MY, Leung M, Tsui D. Comparison of T-Spot. TB and tuberculin skin test among silicotic patients. Eur Respir J 2008;31:266-72.
  • Leung CC, Yew WW. Nitritional deficit in miliary tuberculosis: prognostic value (letter). Eur Respir J 2008;32:1663-4.
  • Hui M, Au-Yeang C, Wong KT, Chan CY, Yew WW, Leung CC. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis. Int J Antimicrob Agents 2008;31:395-6.
  • Yew WW, Chau CH, Wen HK. Linezolid in the treatment of ‘difficult’ multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008;12:345-6.
  • Lee MS, Leung CC, Kam KM, Wong MY, Leung MC, Tam CM, Leung EC. Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberc Lung Dis 2008;12:281-7.
  • Wong MY, Leung CC, Tam CM, Kam KM, Ma CH, Au KF. TB surveillance in correctional institutions in Hong Kong, 1999-2005. Int J Tuberc Lung Dis 2008;12:93-8.
  • Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2008 Sep;12(9):1065-70.
  • Kam KM. Commentary on the English translation of the Lowenstein and Jensen papers. Int J Tuberc Lung Dis 2008;12:1351.
  • Lam TH, Yuen KY, Ho PL, Wong KC, Leong WM, Law HK, Weng XH, Zhang WH, Chen S, Yam WC. Differential fadE28 expression associated with phenotypic virulence of Mycobacterium tuberculosis. Microb Pathog. 2008;45(1):12-7.
  • Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: Update 2007. Respirology 2008;13:21-46.
  • Lee SH. The 60-year battle against tuberculosis in Hong Kong – a review of the past and a projection into the 21st century. Respirology 2008;13(Suppl 3):S49-S55.
  • Leung CC, Chang KC. Impact of lifestyle on tuberculosis. Respirology 2008;13(Suppl 3):S65-S72.
  • Chang KS. Treatment of tuberculosis in presence of hepatic and renal impairment. Respirology 2008;13(Suppl 3):S100-S107.
  • Chang KS. Treatment of tuberculosis in presence of hepatic and renal impairment. Respirology 2008;13(Suppl 3):S100-S107.
  • Yew WW. Management of multidrug-resistant tuberculosis in the Asia-Pacific region. Respirology 2008;13(Suppl 3):S108-S115.
  • Tam CM. Development of new antituberculosis drugs: its relevance worldwide and in the Asia-Pacific region. Respirology 2008;13(Suppl 3):S125-S131.
  • Chan-Yeung M, Lai CKW, Chan KS, Cheung AHK, Yao TJ, Ho ASS, Ko FW, Yam LY, Wong PC, Tsang KW, Lam WK, Ho JC, Chu CM, Yu WC, Chan HS, Ip MSM, Hui DS, Tam CY. The burden of lung disease in Hong Kong: A report from the Hong Kong Thoracic Society. Respirology 2008;13(Suppl 4):S133-S165.
  • Wu P, Cowling BJ, Schooling CM, Wong IO, Johnston JM, Leung CC, Tam CM, Leung GM. Age-period-cohort analysis of tuberculosis notifications in Hong Kong from 1961 to 2005. Thorax 2008;63:312-6.

返回頁首

2007

  • Perlman DC, Leung CC, Yew WW. Treatment of tuberculosis in HIV-infected patients: we need to know more. Am J Respir Crit Care Med 2007;175:1102-3.
  • Yew WW, Leung CC. Antituberculosis drugs and hepatotoxicity (letter). Am J Respir Crit Care Med 2007;175:858-9.
  • Chang KC, Leung CC, Tam CM. Towards optimizing treatment for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2007;175:860.
  • Yew WW, Leung CC. Update in tuberculosis 2006. Am J Respir Crit Care Med 2007;175:541-6.
  • Leung CC, Lam TH, Yew WW. Smoking and tuberculosis: infection, disease, and mortality. Arch Intern Med 2007;167:2008-9.
  • Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G, Law WS, Tam CM, Chan CK, Chang KC. Lower risk of tuberculosis in obesity. Arch Intern Med 2007;167:1297-304.
  • Leung KH, Yip SP, Wong WS, Yiu LS, Chan KK, Lai WM, Chow EY, Lin CK, Yam WC, Chan KS. Sex – and age- dependent association of SLC11A1 polymorphisms with tuberculosis in Chinese: a case control study. BMC Infect Dis 2007 19;7:19.
  • Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA. Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ 2007;85:354-9.
  • Mak JC, Leung HC, Sham AS, Mok TY, Poon YN, Ling SO, Wong KC, Chan-Yeung M. Genetic polymorphisms and plasma levels of transforming growth factors in patients with tuberculosis in Hong Kong. Cytokine 2007; 40:177-82.
  • Vynnycky E, Borgdorff MW, Leung CC, Tam CM, Fine PE. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol Infect 2007 Aug 3:1-10.
  • Chang KC, Leung CC, Yew WW, Tam CM. Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter? Eur Respir J 2007;29:347-51.
  • Leung CC, Yew WW, Law WS, Tam CM, Leung M, Chung YW, Cheung KW, Chan KW, Fu F. Smoking and tuberculosis among silicotic patients. Eur Respir J 2007;29(4):745-50.
  • Pai M, Mohan A, Dheda K, Leung CC, Yew WW, Christopher DJ, Sharma SK. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther. 2007;5:385-91.
  • Chu SF, Tam CM, Wong HS, Kam KM, Lau YL, Chiang AK. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 2007;8:475-9.
  • Lam PK, Wei WI. Medialisation thyroplasty for unilateral vocal cord paralysis associated with chronic pulmonary tuberculosis. Hong Kong Med J 2007;13:330-1.
  • Leung ECC, Leung CC, Tam CM. Delayed presentation and treatment of newly diagnosed pulmonary tuberculosis patients in Hong Kong. Hong Kong Med J 2007;13:221-7.
  • Angra P, Beex-Bleumink M, Gilpin C, Joloba M, Jost K, Kam KM, Kim SJ, Lumb R, Mitarai S, Ramsay A, Ridderhof J, Rieder HL, Selvakumar N, van Beers S, van Cleff M, Van Deun A, Vincent V. Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue? Int J Tuberc Lung Dis 2007;11:1160-1.
  • Tam WO, Yew WW, Yam WC, Yuen KY, Wong PC, Tse TF. Pacemaker infections due to rapidly growing mycobacteria: further experience. Int J Tuberc Lung Dis 2007;11:118.
  • Wong HY, Chau CH, Yew WW. Moxifloxacin-induced arthropathy. Int J Tuberc Lung Dis 2007;11:117.
  • Angra P, Becx-Bleumink M, Gilpin C, Joloba M, Jost K, Kam KM, Kim SJ, Lumb R, Mitarai S, Ramsay A, Ridderhof J, Rieder HL, Selvakumar N, van Beers S, van Cleeff M, Van Deun A, Vincent V. Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue? Int J Tuberc Lung Dis 2007;55(10):1592-7.
  • Lui SL, Yip T, Tse KC, Chan TM, Lai KN, Lo WK. Tuberculosis lymphadenitis in patients undergoing continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2007;39:971-4.
  • Chow KM, Chan NP, Chui KL, Szeto CC. Pancytopenia in a patient with tuberculosis peritonitis. Intern Med J 2007;37:277-7.
  • Chan-Yeung M, Dai DL, Cheung AH, Chan FH, Kam KM, Tam CM, Leung CC. Tuberculin skin test reaction and body mass index in old age home residents in Hong Kong. J Am Geriatr Soc 2007;55:1592-7.
  • Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, Auyeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007;59:866-73.
  • Wong WM, Lai KC, Yiu WC, Wong BC, Chan FL, Lai CL. Intestinal tuberculosis mimicking fistulizing Crohn’s disease. J Gastroenterol Hepatol 2007;22:137-9.
  • Chan AC, Lo CM, Ng KK, Chan SC, Fan ST. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int 2007 ;27; 81-5.
  • Leung CC, Chan CK, Tam CM. HIV-related TB and adverse drug events. Thorax 2007;62:923-4.

返回頁首

2006

  • Yew WW, Leung CC. Update in tuberculosis 2005. Am J Respir Crit Care Med 2006;173:491-8.
  • Yew WW, Leung CC. Prognostic significance of early weight gain in underweight patients with tuberculosis. Am J Respir Crit Care Med 2006;174:236-7.
  • Chang KC, Leung CC, Yew WW, Chan SL, Tam CM. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med 2006;174:1153-8.
  • Leung ET, Ho PL, Yuen KY, Woo WL, Lam TH, Kao RY, Seto WH, Yam WC. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob Agents Chemother 2006;50:1075-8.
  • Leung CC, Yew WW, Chang KC, Tam CM, Chan CK, Law WS, Wong MY, Lee SN, Leung M. Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med 2006;160:247-51.
  • Wong JS, Ng CS, Lee TW, Yim AP. Bronchoscopic management of airway obstruction in pediatric endobronchial tuberculosis. Can Respir J 2006;13:219-21.
  • Kam KM, Yip CW, Tse LW, Leung KL, Wong KL, Kow WM, Wong WS. Optimization of variable number tandem repeat typing set for differentiating Mycobacterium tuberculosis strains in the Beijing family. FEMS Microbiol Lett. 2006;256:258-65.
  • Ho MH, Ho CK, Chong LY. Atypical mycobacterial cutaeous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J 2006;12:21-6.
  • Chan RYC, Kwok AKH. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56-60.
  • Leung VKS, Law ST, Lam CW, Luk ISC, Chau TN, Loke TKL, Chan WH, Lam SH. Intestinal tuberculosis in a regional hospital in Hong Kong: a 10-year experience. Hong Kong Med J 2006;12:264-71.
  • Ho CK, Ho MH, Chong LY. Cutaneous tuberculosis in Hong Kong: an update. Hong Kong Med J 2006;12:272-7.
  • Leung VKS, Chu W, Lee VHM, Chau TN, Law ST, Lam SH. Tuberculosis intestinal perforation during anti-tuberculous treatment. Hong Kong Med J 2006;12:313-5.
  • Tam CM, Leung CC. Occupational tuberculosis: a review of the literature and the local situation. Hong Kong Med J 2006;12:448-55.
  • Leung VKS, Chan WH, Chow TL, Luk ISC, Chau TN, Loke TKL. Oesophageal tuberculosis mimicking oesophageal carcinoma. Hong Kong Med J 2006;12:473-6.
  • Meher R, Agarwal S, Singh I. Tuberculous retropharyngeal abscess in an HIV patient. Hong Kong Med J 2006;12:483-5.
  • Yip CW, Leung KL, Wong D, Cheung DT, Chu MY, Tang HS, Kam KM. Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2006;10:625-30.
  • Yu WC, Lai ST, Chiu MC, Chau TN, Ng TK, Tam CM. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Int J Tuberc Lung Dis 2006;10:824-6.
  • Chan-Yeung M, Cheung AHK, Dai DLK, Chan FHW, Kam KM, Tam CM, Leung CC. Prevalence and determinants of positive tuberculin reactions of residents in old age homes in Hong Kong. Int J Tuberc Lung Dis 2006;10:892-8.
  • Chan-Yeung M, Chan FHW, Cheung AHK, Dai DLK, Chu LW, Lam WK, Leung CC, Kam KM, Tam CM. Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong. J Am Geriatr Soc 2006;54:1334-40.
  • Yam WC, Yuen KY, Kam SY, Yiu LS, Chan KS, Leung CC, Tam CM, Ho PO, Yew WW, Seto WH, Ho PL. Diagnostic application of genotypic identification of mycobacteria. J Med Micriobiol 2006;55:529-36.
  • Kam KM, Yip CW, Cheung TL, Tang HS, Leung OC, Chan MY. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. Microb Drug Resist 2006; 12:7-11.
  • Chan-Yeung M, Kam KM, Leung CC, Wang J, Yew WW, Lam CW, Tam CM. Population-based prospective molecular and conventional epidemiological study of tuberculosis in Hong Kong. Respirology 2006;11(4):442-8.
  • Yew WW, Leung CC. Antituberculosis drugs and hepatotoxicity. Respirology 2006;11:699-707.
  • Davies PD, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, Rook GA. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006;100:291-8.

返回頁首